These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12875196)

  • 1. [Principles of antibacterial therapy of sepsis].
    Igonin AA; Kukes VG
    Klin Med (Mosk); 2003; 81(6):61-5. PubMed ID: 12875196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of three antimicrobial drugs protocol (Ceftriaxone, Gentamicin/Amikacin and Metronidazole) versus two antimicrobial drugs protocol (Ceftriaxone and Metronidazole) in cases of intra-abdominal sepsis.
    Khan S; Gupta DK; Khan DN
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):55-63. PubMed ID: 16401946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A strategy and procedure for the antibacterial therapy of abdominal sepsis].
    Gel'fand BR; Gologorskiĭ VA; Ge'lfand EB; Alekseeva EA; Briukhov AN
    Anesteziol Reanimatol; 1998; (4):16-9. PubMed ID: 9770811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-antibiotic strategies for sepsis.
    Cohen J
    Clin Microbiol Infect; 2009 Apr; 15(4):302-7. PubMed ID: 19416301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics in sepsis and septic shock: like everything else in life, timing is everything.
    Zubert S; Funk DJ; Kumar A
    Crit Care Med; 2010 Apr; 38(4):1211-2. PubMed ID: 20335700
    [No Abstract]   [Full Text] [Related]  

  • 7. Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial.
    Orozco H; Arch J; Medina-Franco H; Pantoja JP; González QH; Vilatoba M; Hinojosa C; Vargas-Vorackova F; Sifuentes-Osornio J
    Arch Surg; 2006 Feb; 141(2):150-3; discussion 154. PubMed ID: 16490891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of sepsis.
    Girbes AR; Beishuizen A; Strack van Schijndel RJ
    Fundam Clin Pharmacol; 2008 Aug; 22(4):355-61. PubMed ID: 18705746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sepsis management -- antibiotic therapy].
    Welte T
    Dtsch Med Wochenschr; 2004 Nov; 129(48):2609-13. PubMed ID: 15558411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sepsis: new insights into its pathogenesis and treatment].
    Wiersinga WJ; van der Poll T
    Ned Tijdschr Geneeskd; 2010; 154():A1130. PubMed ID: 20170566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.
    MacArthur RD; Miller M; Albertson T; Panacek E; Johnson D; Teoh L; Barchuk W
    Clin Infect Dis; 2004 Jan; 38(2):284-8. PubMed ID: 14699463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis.
    Schmit X; Vincent JL
    Infection; 2008 Jun; 36(3):213-9. PubMed ID: 18463788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First choice in empiric treatment of sepsis].
    Bucher A; Øie E
    Tidsskr Nor Laegeforen; 2004 Dec; 124(24):3264. PubMed ID: 15645537
    [No Abstract]   [Full Text] [Related]  

  • 14. Can one plus one ever equal three in the antibiotic therapy of sepsis?
    Niederman MS
    Crit Care Med; 2010 Sep; 38(9):1906-8. PubMed ID: 20724888
    [No Abstract]   [Full Text] [Related]  

  • 15. Does antibiotic selection impact patient outcome?
    Harbarth S; Nobre V; Pittet D
    Clin Infect Dis; 2007 Jan; 44(1):87-93. PubMed ID: 17143822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical expirience in the treatment of purulent meningitis and sepsis with Ceftriaxon].
    Dulović O; Pavlović M; Nikolić S; Vujosević M; Canić M
    Srp Arh Celok Lek; 1990; 118(3-4):141-4. PubMed ID: 17977403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving survival for sepsis: on the cutting edge.
    Rello J; Rodriguez A
    Crit Care Med; 2003 Dec; 31(12):2807-8. PubMed ID: 14668621
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic challenge of Gram-negative sepsis: prolonging the lifespan of a scarce resource.
    Richards GA
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():18-22. PubMed ID: 16209702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis.
    Huttunen R; Aittoniemi J
    J Infect; 2011 Dec; 63(6):407-19. PubMed ID: 21840338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs and cost-effectiveness of an integrated sepsis treatment protocol.
    Talmor D; Greenberg D; Howell MD; Lisbon A; Novack V; Shapiro N
    Crit Care Med; 2008 Apr; 36(4):1168-74. PubMed ID: 18379243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.